Peptide derived nanobody inhibits entry of SARS-CoV-2 variants
N. Mendon, R. A. Ganie, S. Kesarwani, D. Dileep, S. Sasi, P. Lama, A. Chandra, M. Sirajuddin
The paper identifies a nanobody that inhibits SARS-CoV-2 entry by targeting a peptide from the spike protein's receptor-binding motif, showing efficacy against multiple variants.
bioRxiv · Apr 21, 2022 · PreprintCell Biology